                         SEQUENCE LISTING

<110>  Scott, Kieran and Church, William Bret
 
<120>  Method of screening for inhibitors of sPLA2-IIA

<130>  510958

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  997
<212>  DNA
<213>  Homo sapiens

<400>  1
gaaggaaaaa gagcaacaga tccagggagc attcacctgc cctgtctcca aacagccttg       60

tgcctcacct acccccaacc tcccagaggg agcagctatt taaggggagc aggagtgcag      120

aacaaacaag acggcctggg gatacaactc tggagtcctc tgagagagcc accaaggagg      180

agcaggggag cgacggccgg ggcagaagtt gagaccaccc agcagaggag ctaggccagt      240

ccatctgcat ttgtcaccca agaactctta ccatgaagac cctcctactg ttggcagtga      300

tcatgatctt tggcctactg caggcccatg ggaatttggt gaatttccac agaatgatca      360

agttgacgac aggaaaggaa gccgcactca gttatggctt ctacggctgc cactgtggcg      420

tgggtggcag aggatccccc aaggatgcaa cggatcgctg ctgtgtcact catgactgtt      480

gctacaaacg tctggagaaa cgtggatgtg gcaccaaatt tctgagctac aagtttagca      540

actcggggag cagaatcacc tgtgcaaaac aggactcctg cagaagtcaa ctgtgtgagt      600

gtgataaggc tgctgccacc tgttttgcta gaaacaagac gacctacaat aaaaagtacc      660

agtactattc caataaacac tgcagaggga gcacccctcg ttgctgagtc ccctcttccc      720

tggaaacctt ccacccagtg ctgaatttcc ctctctcata ccctccctcc ctaccctaac      780

caagttcctt ggccatgcag aaagcatccc tcacccatcc tagaggccag gcaggagccc      840

ttctataccc acccagaatg agacatccag cagatttcca gccttctact gctctcctcc      900

acctcaactc cgtgcttaac caaagaagct gtactccggg gggtctcttc tgaataaagc      960

aattagcaaa aaaaaaaaaa aaaaaaaaaa aaaaaaa                               997


<210>  2
<211>  144
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Lys Thr Leu Leu Leu Leu Ala Val Ile Met Ile Phe Gly Leu Leu 
1               5                   10                  15      


Gln Ala His Gly Asn Leu Val Asn Phe His Arg Met Ile Lys Leu Thr 
            20                  25                  30          


Thr Gly Lys Glu Ala Ala Leu Ser Tyr Gly Phe Tyr Gly Cys His Cys 
        35                  40                  45              


Gly Val Gly Gly Arg Gly Ser Pro Lys Asp Ala Thr Asp Arg Cys Cys 
    50                  55                  60                  


Val Thr His Asp Cys Cys Tyr Lys Arg Leu Glu Lys Arg Gly Cys Gly 
65                  70                  75                  80  


Thr Lys Phe Leu Ser Tyr Lys Phe Ser Asn Ser Gly Ser Arg Ile Thr 
                85                  90                  95      


Cys Ala Lys Gln Asp Ser Cys Arg Ser Gln Leu Cys Glu Cys Asp Lys 
            100                 105                 110         


Ala Ala Ala Thr Cys Phe Ala Arg Asn Lys Thr Thr Tyr Asn Lys Lys 
        115                 120                 125             


Tyr Gln Tyr Tyr Ser Asn Lys His Cys Arg Gly Ser Thr Pro Arg Cys 
    130                 135                 140                 


